Diazyme Laboratories, Inc.

Home
United States
Poway, CA
Diazyme Laboratories, Inc.

Diazyme is a clinical chemistry reagent manufacturer that develops IVD assays for use on conventional open channel automated chemistry platforms.

02/27/2026

Diazyme continues to advance cardiovascular diagnostics with solutions that enhance laboratory efficiency and clinical insight. The OxLDL Assay provides fast, automated, cost efficient measurement of oxidized LDL and uncovers risk elements standard lipid tests can miss.

Key Advantages:
• Fast and Automated: Streamlines testing for more efficient laboratory workflows
• Cost-Efficient: Offers a practical alternative for broader cardiovascular testing
• Early Detection: Identifies oxidized LDL and plaque-related risk before traditional markers
• Comprehensive Insight: Measures risk factors not captured by standard cholesterol tests

Discover more about the OxLDL Assay: https://bit.ly/4g1RzhW

02/23/2026

Congenital Heart Defect Awareness Week | The Role of Cardiovascular Biomarkers:

Congenital Heart Defects (CHDs) are the most common birth defects, affecting nearly 1 in 100 newborns. While CHDs are present from birth, monitoring cardiovascular health throughout life is essential for managing potential complications. (https://bit.ly/3Z5aToh)

At Diazyme, our cardiovascular biomarkers help provide critical insights into heart health:
🔹 Homocysteine (HCY): Elevated levels are associated with an increased risk of congenital heart defects and may contribute to cardiovascular disease progression. (https://bit.ly/4q8feCf)
🔹 Lipoprotein(a) [Lp(a)]: A genetically inherited lipoprotein recognized as an independent risk factor for cardiovascular diseases. Elevated Lp(a) levels can adversely affect cardiovascular health in individuals with congenital heart disease (CHD). Monitoring Lp(a) concentrations in these patients is crucial for assessing and managing the risk of additional cardiovascular complications.
(https://bit.ly/4raQTwm)

Raising awareness and improving early detection can make a difference in the lives of those living with CHDs. 💙

Learn more about our Cardiovascular Panel featuring items like OxPL, Apo A, PLAC™ & More: https://bit.ly/3MlnU6y

02/18/2026

Diazyme offers a broad menu of cardiovascular marker assays, including sdLDL, lipoprotein(a), oxLDL, HDL3, and apolipoproteins. These assays support standardized measurement of lipid and lipoprotein markers used in cardiovascular risk assessment.

Explore the full assay menu at https://bit.ly/3C8vYpH

02/17/2026

At Diazyme, we are committed to advancing clinical diagnostics with innovative assays that help clinicians uncover deeper insights into cardiovascular risk factors beyond traditional testing. Our portfolio of cardiovascular biomarkers supports more comprehensive risk assessment, enabling earlier identification of at‑risk patients and more informed clinical decision‑making. These assays reflect our dedication to expanding diagnostic capabilities that can improve patient care and outcomes.

Explore our full cardiovascular biomarker solutions and learn how they can support your laboratory or clinical practice: https://bit.ly/3MlnU6y

02/12/2026

Day 2 & 3 at WHX Labs!

Thank you to everyone who stopped by, asked questions, and shared ideas. We're excited about what's ahead—and we’re proud to continue supporting laboratories with powerful, accessible diagnostic solutions.

Stay Connected with Diazyme after the show: https://www.diazyme.com/contact/

02/12/2026

Discover Diazyme’s sdLDL Assay

Accurately quantify small dense LDL-cholesterol (sdLDL-C) with a homogeneous direct enzymatic method. Diazyme’s sdLDL Assay delivers fast, reliable results using liquid-stable reagents, with no pretreatment or complex workflows required.

• Direct measurement of sdLDL-C
• Results in 10 minutes
• Compatible with most automated clinical chemistry analyzers

Learn more: https://bit.ly/4tjkTIq

For Research Use Only.

02/10/2026

Day 1 at WHX Labs 2026!

We're excited to kick off our first day at the WHX Labs this year! It's an incredible opportunity to connect with industry professionals, showcase our latest innovations, and discuss how our comprehensive range of assays are advancing clinical chemistry worldwide.

Visit us at our booth and explore how Diazyme is working to shape the future of diagnostics!

Reserve a meeting time here: https://bit.ly/4jtxWT3

02/09/2026

🎉 WHX Labs 2026 kicks off tomorrow!

We’re ready to meet you, share what’s new at Diazyme, and dive into the future of diagnostics together.

📍 Visit Booth H3.G16 and follow us for daily show highlights!

Reserve a meeting here: https://bit.ly/4jtxWT3

02/05/2026

What Is the PLAC test?

The PLAC® Test for Lp-PLA2 Activity (PLAC Activity) is the only FDA cleared test for Lp-PLA2 activity with a clinically validated cut-point and is exclusively offered by Diazyme Laboratories!

Learn how to advance your laboratories by adding PLAC today! Visit this site to learn more:
https://bit.ly/3UH7BGf

02/03/2026

February is American Heart Month ❤️

Cardiovascular disease remains the leading cause of death worldwide, but early detection can save lives. Diazyme’s Cardiovascular Panel offers fast, reliable insights to help identify risks and support better heart health management.

From Lp-PLA₂ (PLAC™) for vascular inflammation to oxLDL for assessing oxidative stress, our assays provide the tools clinicians need for proactive care. Let’s work together to make heart health a priority!

Learn more: https://bit.ly/3MlnU6y

02/02/2026

One week to go until WHX Labs Dubai, February 10–13. We’re looking forward to connecting with industry leaders and discussing the latest advances in clinical diagnostics.

📍 Visit us at Booth H3.G16
📅 Schedule your one-on-one meeting with our team today - https://bit.ly/4jtxWT3

We look forward to seeing you in Dubai.

01/27/2026

What Sets Diazyme Laboratories Apart?

At Diazyme Laboratories, we pride ourselves on offering diagnostic solutions that lead the industry in innovation and reliability. Here’s what makes us stand out:

🔬 Innovative Technology: Our assays are designed with cutting-edge technology to deliver precise and dependable results. Our solutions support early detection and effective management across various medical conditions.

💡 Comprehensive Assay Menu: We provide an extensive range of FDA-cleared assays, covering a wide array of diagnostic needs. This breadth ensures our clients have access to comprehensive diagnostic tools for diverse applications.

📈 High-Performance Efficiency: With products like the DZ-Lite™ c270 analyzer, we offer rapid and accurate results with high throughput. Our solutions enhance efficiency, enabling healthcare professionals to make timely and informed decisions.

🛠️ User-Friendly Design: Our instruments are crafted for ease of use and seamless integration. From intuitive interfaces to compact designs, we prioritize user experience to fit diverse clinical environments.

🌍 Commitment to Quality: Quality and reliability are at the core of our mission. We are committed to continuous improvement, ensuring that our diagnostic tools meet the highest standards of excellence.

Discover how Diazyme Laboratories can enhance your diagnostic capabilities and support better patient outcomes: https://bit.ly/36lKaaV

Address

12889 Gregg Court
Poway, CA
92064

Website

http://www.diazyme.com/

Alerts

Be the first to know and let us send you an email when Diazyme Laboratories, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Want your practice to be the top-listed Clinic in Poway?